loading

Aurinia Pharmaceuticals Inc Borsa (AUPH) Ultime notizie

pulisher
Jul 22, 2025

What analysts say about Aurinia Pharmaceuticals Inc. stockDynamic investment opportunities - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Aurinia Pharmaceuticals Inc. stock priceHigh-yield investments - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025 - BioSpace

Jul 22, 2025
pulisher
Jul 22, 2025

Aurinia Pharmaceuticals to Announce Q2 2025 Financial Results - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

Aurinia Pharmaceuticals: LUPKYNIS Growth and AUR200 Pipeline Fuel Long-Term Value - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

ISS Recommends That Aurinia Shareholders Vote "FOR" All Proposals at 2025 Annual General Meeting - Yahoo.co

Jul 22, 2025
pulisher
Jul 22, 2025

Aurinia Pharmaceuticals Inc. Stock Analysis and ForecastBreakthrough investment results - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Is Aurinia Pharmaceuticals Inc. a good long term investmentFree AI-Backed Trading Signals - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

(AUPH) Technical Data - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 18, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Delivers Shareholders Favorable 52% Return Over 1 Year, Surging 5.5% in the Last Week Alone - 富途牛牛

Jul 18, 2025
pulisher
Jul 17, 2025

Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics - Yahoo

Jul 17, 2025
pulisher
Jul 15, 2025

What makes Aurinia Pharmaceuticals Inc. stock price move sharplyDaily Breakout Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Aurinia Pharmaceuticals Inc. stock performs during market volatilityFree Stock Investment Discussion Area - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Aurinia Pharmaceuticals Inc. stock attracts strong analyst attentionReal Trader Insights - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

How did AUPH's Q3 2024 earnings surprise impact short-term traders? - AInvest

Jul 10, 2025
pulisher
Jul 09, 2025

Trading (AUPH) With Integrated Risk Controls - news.stocktradersdaily.com

Jul 09, 2025
pulisher
Jul 08, 2025

Wheat from chaff in BAFF: APRIL’s advent for Aurinia? - BioWorld MedTech

Jul 08, 2025
pulisher
Jul 07, 2025

The Play On Aurinia Pharmaceuticals: Rising Cash Flow Provides Opportunity (NASDAQ:AUPH) - Seeking Alpha

Jul 07, 2025
pulisher
Jul 06, 2025

Retail Bulls Charge Into Aurinia Pharmaceuticals Ahead Of Autoimmune Trial Results - MSN

Jul 06, 2025
pulisher
Jul 02, 2025

Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options - Nasdaq

Jul 02, 2025
pulisher
Jul 02, 2025

Implied Volatility Surging For Aurinia Pharmaceuticals Stock Options - Barchart.com

Jul 02, 2025
pulisher
Jul 01, 2025

Leerink Partners Keeps Their Buy Rating on Aurinia Pharmaceuticals (AUPH) - The Globe and Mail

Jul 01, 2025
pulisher
Jun 30, 2025

Aurinia’s aritinercept shows promising results in phase 1 study - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200) - New Castle News

Jun 30, 2025
pulisher
Jun 30, 2025

Aurinia Pharmaceuticals Inc.(NasdaqGM: AUPH) added to Russell 2000 Defensive Index - MarketScreener

Jun 30, 2025
pulisher
Jun 29, 2025

(AUPH) Trading Report - news.stocktradersdaily.com

Jun 29, 2025
pulisher
Jun 29, 2025

Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025 - The Joplin Globe

Jun 29, 2025
pulisher
Jun 27, 2025

Aurinia (AUPH) Surges 7.5%: Is This an Indication of Further Gains? - Yahoo Finance

Jun 27, 2025
pulisher
Jun 26, 2025

Aurinia shares rise ahead of key autoimmune therapy data - Proactive financial news

Jun 26, 2025
pulisher
Jun 21, 2025

Shareholders in Aurinia Pharmaceuticals (NASDAQ:AUPH) have lost 50%, as stock drops 5.0% this past week - simplywall.st

Jun 21, 2025
pulisher
Jun 15, 2025

With 51% institutional ownership, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a favorite amongst the big guns - Yahoo Finance

Jun 15, 2025
pulisher
Jun 12, 2025

Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarkets™METRO - METRO - NEWS CHANNEL NEBRASKA

Jun 12, 2025
pulisher
Jun 11, 2025

California State Teachers Retirement System Sells 13,824 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Shares Sold by Bank of America Corp DE - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Are Options Traders Betting on a Big Move in Aurinia Pharmaceuticals (AUPH) Stock? - MSN

Jun 10, 2025
pulisher
Jun 10, 2025

As Edmonton biotech industry booms, Launa Aspeslet steps up to guide further success - Taproot Edmonton

Jun 10, 2025
pulisher
Jun 08, 2025

Wellington Management Group LLP Buys New Shares in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress - mx.advfn.com

Jun 07, 2025
pulisher
Jun 07, 2025

Millennium Management LLC Increases Stake in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

Jun 07, 2025
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Capitalizzazione:     |  Volume (24 ore):